Alex la Croix

Alex La Croix has a diverse work experience in the biopharmaceutical industry. Starting in 2000, they worked as a Manager of Business Development at Targeted Genetics Corporation, where they provided assessments on disease targets and technology platforms. They then moved on to Genzyme Genetics, where they served as the Manager of Market Research and played a key role in expanding the company's business and entering new therapeutic areas.

In 2007, La Croix joined Shire Pharmaceuticals and held various roles, including Global Commercial Leader and Director of New Product Strategy. They were responsible for driving global strategy for Shire's enzyme replacement brand and evaluating research projects for pipeline investment.

La Croix's work experience continued at Synageva BioPharma Corp., where they were Head of Marketing. They led the development and implementation of disease awareness and market development strategies.

At Agios Pharmaceuticals, La Croix served as a Director of New Product Planning, Senior Director of Rare Genetic Disease Marketing, and Global Commercial Lead for Fabry disease at Sanofi Genzyme. They were responsible for strategic marketing, commercial execution, and cross-functional collaboration.

La Croix also held the position of Global Head of Business Development at PTC Therapeutics, where they developed a proactive business strategy and led a team in sourcing, evaluating, and negotiating growth opportunities for the company.

Most recently, La Croix was the Founder and Lead at Aspira Strategies and currently holds the position of Franchise Program Lead for the Movement Disorder portfolio at Praxis Precision Medicines, Inc.

Overall, La Croix has extensive experience in various aspects of the biopharmaceutical industry, including business development, commercial strategy, marketing, and market research.

Alex La Croix has a diploma in College Prep from Amos Alonzo Stagg Senior High School (Stockton, CA), obtained in 1988. In 1993, Alex completed a Bachelor of Arts (BA) degree in Latin American Studies from the University of California, Berkeley. In 2003, they earned an MBA in Finance and Marketing from Boston College Carroll School of Management. In 2020, they attended Harvard Business School Executive Education for a course in Changing the Game: Negotiation and Competitive Decision-Making. Additionally, Alex has obtained certifications such as Scrum Product Owner Certified from Scrum Alliance in 2019, Leading Teams for Impact from the Center for Creative Leadership in 2017, and Leadership Development Program (LDP) from the Center for Creative Leadership in 2015.